Democrats Take Aim At Drug Prices; Biotech Stocks Drop

Democratic lawmakers attacked "massive" price increases of two heart drugs from Canada's Valeant Pharmaceuticals International Inc, sparking a rout in drugmakers' shares on worries of a broad government and insurer clamp down on U.S. drug prices. All 18 Democratic members of the House Committee on Oversight and Government Reform urged their chairman on Monday to subpoena Valeant to force it to provide documents relating to price increases of 212 percent and 525 percent, respectively, for Isuprel...